IronBridge Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$21.4M Sell
253,966
-245,064
-49% -$19.6M 1.29% 19
2016
Q4
$36.7M Buy
499,030
+59,920
+14% +$4.46M 1.64% 14
2016
Q3
$35.2M Sell
439,110
-17,770
-4% -$1.42M 1.62% 14
2016
Q2
$36M Sell
456,880
-90
-0% -$6.78K 1.58% 17
2016
Q1
$32.9M Buy
456,970
+104,220
+30% +$7.89M 1.32% 22
2015
Q4
$29.7M Buy
+352,750
New +$29.3M 1.17% 25

Other funds holding LLY

IronBridge Capital Management's LLY Position: Q1 2017 in Review

IronBridge Capital Management reduced its Eli Lilly (LLY) stake by 49% in Q1 2017, selling an estimated $19.6M and leaving 253,966 shares worth $21.4M. The position accounts for 1.29% of the portfolio, ranked #19.

IronBridge Capital Management first reported a position in LLY in Q4 2015 and has held it in 6 quarters since. The position peaked at $36.7M in Q4 2016. 1,249 funds tracked by Wall St. Rank hold LLY as of Q1 2017.

  • IronBridge Capital Management held 253,966 shares of Eli Lilly worth $21.4M as of Q1 2017.
  • IronBridge Capital Management sold 245,064 Eli Lilly shares in Q1 2017, an estimated $19.6M.
  • Eli Lilly made up 1.29% of IronBridge Capital Management's portfolio in Q1 2017, its #19 holding.
  • IronBridge Capital Management first reported a position in Eli Lilly in Q4 2015 and has held it in 6 quarters since.
  • IronBridge Capital Management's Eli Lilly position peaked at $36.7M in Q4 2016.
  • 1,249 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2017.

Based on IronBridge Capital Management's 13F filing for Q1 2017, filed 10 May 2017.